logo
logo
AI + EXCLUSIVE DATA

AI tracks executive moves from sources others don't have

Our proprietary AI analyzes exclusive hiring data to find decision-makers actively evaluating solutions like yours.

10-25 executive leads daily • Direct contact info • First 90 days targeting
Start with:
✓Flexible Plans • $39/mo or $29/mo annual
✓AI + proprietary hiring database
✓Executive contact details included
INDUSTRY FIRST

Amicus Therapeutics Appoints Simon Harford As Chief

Aug 21, 2023•almost 2 years ago

Company

AMICUS THERAPEUTICS INC

Simon Harford
PhiladelphiaTherapeuticsHealth CareBiotechnology

Description

PHILADELPHIA, Aug. 21, 2023 -- Amicus Therapeutics , a patient-dedicated global biotechnology company focused on developing and commercializing novel medicines for rare diseases, today announced that Simon Harford has been appointed Chief Financial Officer, effective immediately. Simon brings extensive financial leadership experience, having served in significant finance roles in two global pharmaceutical companies as well as most recently as a public company CFO in the biotechnology industry

Company Information

Company

AMICUS THERAPEUTICS INC

Location

1 Cedar Brook Drive

Philadelphia, Pennsylvania, United States

About

We are leveraging our innovative technology platforms to develop treatments for human genetic diseases. Join a team committed to changing the lives of patients with rare metabolic diseases. Now hiring in multiple locations.

FundzWatch™ Score

62
Medium Activity

Related People

Sign in to view contact details

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months